{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T09:03:56Z","timestamp":1771664636506,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["171002214"],"award-info":[{"award-number":["171002214"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jtha.2025.04.030","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T11:12:04Z","timestamp":1747134724000},"page":"2558-2567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Elevated levels of (active) von Willebrand factor during anticoagulation are associated with early recurrence of venous thromboembolism"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4520-9732","authenticated-orcid":false,"given":"Geke C.","family":"Poolen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1601-9393","authenticated-orcid":false,"given":"Rolf T.","family":"Urbanus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Roest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert\u2013Jan","family":"Geersing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bas","family":"de Laat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger E.G.","family":"Schutgens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.04.030_bib1","article-title":"Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis","volume":"366","author":"Khan","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2025.04.030_bib2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.thromres.2020.12.031","article-title":"Prediction models for recurrence and bleeding in patients with venous thromboembolism: a systematic review and critical appraisal","volume":"199","author":"de Winter","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.04.030_bib3","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/eurheartj\/ehac776","article-title":"Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score","volume":"44","author":"de Winter","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2025.04.030_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113176","article-title":"Immunothrombosis and the role of platelets in venous thromboembolic diseases","volume":"23","author":"Heestermans","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2025.04.030_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/bjh.15869","article-title":"Advances in understanding the molecular mechanisms of venous thrombosis","volume":"186","author":"Preston","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.04.030_bib6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/ATVBAHA.108.162289","article-title":"Mechanisms of venous thrombosis and resolution","volume":"28","author":"Wakefield","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2025.04.030_bib7","first-page":"117","article-title":"Haemopathological changes in recurrent deep venous thrombosis of the extremities","volume":"23","author":"Sakaguchi","year":"1982","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.jtha.2025.04.030_bib8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1160\/TH08-06-0384","article-title":"Antiphospholipid antibodies predict imminent vascular events independently from other risk factors in a prospective cohort","volume":"101","author":"Neville","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.030_bib9","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/jth.13113","article-title":"Predictive value of factor VIII levels for recurrent venous thrombosis: results from the MEGA follow-up study","volume":"13","author":"Timp","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.030_bib10","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1160\/TH07-02-0115","article-title":"Circulating P-selectin and the risk of recurrent venous thromboembolism","volume":"97","author":"Kyrle","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.030_bib11","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1373\/clinchem.2006.085068","article-title":"High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variant","volume":"53","author":"Ay","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.jtha.2025.04.030_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fcvm.2019.00033","article-title":"Searching for a common thrombo-inflammatory basis in patients with deep vein thrombosis or peripheral artery disease","volume":"6","author":"Kremers","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jtha.2025.04.030_bib13","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.thromres.2011.06.003","article-title":"Whole blood gene expression analyses in patients with single versus recurrent venous thromboembolism","volume":"128","author":"Lewis","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.04.030_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003142","article-title":"Effect of tailoring anticoagulant treatment duration by applying a recurrence risk prediction model in patients with venous thromboembolism compared to usual care: a randomized controlled trial","volume":"17","author":"Geersing","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.jtha.2025.04.030_bib15","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.109.925214","article-title":"Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model","volume":"121","author":"Eichinger","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2025.04.030_bib16","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1182\/blood-2005-03-1153","article-title":"A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B","volume":"106","author":"Hulstein","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.04.030_bib17","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1046\/j.1365-2141.2003.04795.x","article-title":"High plasma levels of factor VIII and risk of recurrence of venous thromboembolism","volume":"124","author":"Cristina","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.04.030_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJM200008173430702","article-title":"High plasma levels of factor VIII and the risk of recurrent venous thromboembolism","volume":"343","author":"Kyrle","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.04.030_bib19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.thromres.2015.05.002","article-title":"B blood group: a strong risk factor for venous thromboembolism recurrence","volume":"136","author":"Baudouy","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.04.030_bib20","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood.2020005843","article-title":"The relationship between ABO blood group, von Willebrand factor, and primary hemostasis","volume":"136","author":"Ward","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.04.030_bib21","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3892\/etm.2020.9574","article-title":"Identification of thrombomodulin as a dynamic monitoring biomarker for deep venous thrombosis evolution","volume":"21","author":"Cheng","year":"2021","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jtha.2025.04.030_bib22","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1007\/s00415-024-12268-6","article-title":"Sex differences in modifiable risk factors for stroke incidence and recurrence: the UCC-SMART study","volume":"271","author":"Rissanen","year":"2024","journal-title":"J Neurol"},{"key":"10.1016\/j.jtha.2025.04.030_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/eurjpc\/zwae175.095","article-title":"Sex differences in risk factor relationships with subarachnoid haemorrhage and intracranial aneurysms: a Mendelian randomisation study","volume":"31","author":"Tschiderer","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jtha.2025.04.030_bib24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1503\/cmaj.080493","article-title":"Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy","volume":"179","author":"Rodger","year":"2008","journal-title":"CMAJ"},{"key":"10.1016\/j.jtha.2025.04.030_bib25","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.thromres.2014.11.007","article-title":"Combined oral contraceptives do not influence von Willebrand factor related biomarkers despite an induced acute phase response","volume":"135","author":"Larsen","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.04.030_bib26","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1111\/j.1538-7836.2006.02273.x","article-title":"von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis","volume":"4","author":"Nossent","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.030_bib27","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/jth.13294","article-title":"Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms","volume":"14","author":"Alb\u00e1nez","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.030_bib28","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.3390\/cancers14112771","article-title":"Biomarkers of venous thromboembolism recurrence after discontinuation of low molecular weight heparin treatment for cancer-associated thrombosis (HISPALIS-Study)","volume":"14","author":"Otero","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jtha.2025.04.030_bib29","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood-2009-08-237354","article-title":"Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study","volume":"115","author":"Cosmi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.04.030_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219751","article-title":"D-dimer levels during and after anticoagulation withdrawal in patients with venous thromboembolism treated with non-vitamin K anticoagulants","volume":"14","author":"Legnani","year":"2019","journal-title":"PLOS One"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625003137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625003137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:11:10Z","timestamp":1762549870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625003137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1538783625003137"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.04.030","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated levels of (active) von Willebrand factor during anticoagulation are associated with early recurrence of venous thromboembolism","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.04.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}